GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
NASDAQ:DRNA
Delisted

Dicerna Pharmaceuticals Stock Price (Quote)

$38.22
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $38.22 $38.22 Friday, 27th May 2022 DRNA stock ended at $38.22. During the day the stock fluctuated 0% from a day low at $38.22 to a day high of $38.22.
90 days $38.22 $38.22
52 weeks $19.06 $40.14

Historical Dicerna Pharmaceuticals prices

Date Open High Low Close Volume
2019-07-15 $14.27 $14.46 $14.08 $14.20 297 775
2019-07-12 $14.28 $14.49 $14.13 $14.20 519 506
2019-07-11 $14.50 $14.63 $14.16 $14.30 362 594
2019-07-10 $14.73 $14.85 $14.32 $14.50 443 530
2019-07-09 $14.57 $14.83 $14.47 $14.58 321 040
2019-07-08 $14.77 $15.06 $14.44 $14.59 241 737
2019-07-05 $14.88 $15.11 $14.72 $14.74 206 627
2019-07-03 $14.70 $15.04 $14.70 $14.98 133 271
2019-07-02 $15.35 $15.41 $14.61 $14.78 362 287
2019-07-01 $15.75 $15.94 $15.44 $15.61 289 090
2019-06-28 $15.75 $16.17 $15.53 $15.75 777 781
2019-06-27 $15.82 $16.12 $15.52 $15.75 303 930
2019-06-26 $15.92 $16.14 $15.60 $15.83 182 983
2019-06-25 $15.47 $16.31 $15.43 $15.80 386 501
2019-06-24 $15.51 $15.71 $15.10 $15.38 335 330
2019-06-21 $15.28 $15.73 $15.05 $15.50 751 114
2019-06-20 $15.65 $16.00 $15.30 $15.44 331 025
2019-06-19 $15.87 $16.06 $15.27 $15.39 476 236
2019-06-18 $16.06 $16.95 $15.73 $15.90 639 284
2019-06-17 $14.95 $15.90 $14.58 $15.84 512 287
2019-06-14 $15.00 $15.25 $14.75 $14.76 334 582
2019-06-13 $14.44 $15.39 $14.17 $15.08 664 341
2019-06-12 $13.65 $14.55 $13.44 $14.45 301 024
2019-06-11 $13.72 $14.14 $13.57 $13.68 341 375
2019-06-10 $13.04 $13.65 $12.81 $13.54 606 354
Click to get the best stock tips daily for free!

About Dicerna Pharmaceuticals

Dicerna Pharmaceuticals Dicerna Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery and development of treatments for liver diseases and cancers based on a proprietary RNA interference technology platform in the United States and internationally. The company’s development programs include DCR-PH1 for the treatment of primary hyperoxaluria type 1 (PH1) through targeting the gene encoding the liver enzyme glycolate oxidase; and other rare inherit... DRNA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT